News Headline Summary

FDA approves Celgene (CELG) Pomalidomide in multiple Myeloma

Reaction details (20:34)

- In reaction to this news co. shares moved 0.85% higher to trade at USD 100.86 last.

08 Feb 2013 - 20:30 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: